Small cell lung carcinoma with KIF5B-RET fusion partially responded to the 4th-line therapy with anlotinib: A case report

doi:10.12998/wjcc.v12.i23.5410

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

HTML

Figures (1-2)

Sum=8

Aug 16, 2024 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 16, 2024; 12(23): 5410-5415
Published online Aug 16, 2024. doi: 10.12998/wjcc.v12.i23.5410

Full Size Figure Download Figure

Figure 1 Chest computed tomography and histological evaluation. A-C: The baseline chest computed tomography assessment in May 2021 included evaluation of lung lesions, lymph node lesions, and pleural lesions; D-F: Hematoxylin and eosin staining with magnifications of 100 x, 200 x, and 400 x revealed extensive-stage disease small cell lung cancer (SCLC) classification; G-L: Immunohistochemical staining displayed cytokeratin CAM5.2, CD56, Ki67, synaptophysin, chromogranin A, and thyroid transcription factor-1 in the SCLC tumor biopsy.

Citation: Zhang R, He YT, Liu YS, Li H, Zhao F. Small cell lung carcinoma with KIF5B-RET fusion partially responded to the 4^th-line therapy with anlotinib: A case report. World J Clin Cases 2024; 12(23): 5410-5415
URL: https://www.wjgnet.com/2307-8960/full/v12/i23/5410.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i23.5410